Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

Tuesday’s trading has closed, but ALNY is being traded in the after-hours session. After-Hours quote »
119.89
Delayed Data
As of 3:59pm ET
 +5.68 / +4.97%
Today’s Change
51.93
Today|||52-Week Range
140.00
+23.60%
Year-to-Date

Today’s Trading

Previous close114.21
Today’s open116.94
Day’s range114.63 - 120.39
Volume755,257
Average volume (3 months)807,327
Market cap$9.6B
Dividend yield--
Data as of 3:59pm ET, 06/30/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+38.24%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book9.42

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+0.53+0.74%
ISISIsis Pharmaceuticals...+1.47+2.62%
ICLRICON PLC+1.09+1.65%
DYAXDyax Corp+0.61+2.36%
Data as of 4:04pm ET, 06/30/2015

Financials

Next reporting dateAugust 3, 2015
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers